Brilinta 90 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F4ZNW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,453
Award facts
- Contract value 100% obligated
- $10,453.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $10,453.05 to AmerisourceBergen Drug Corp for the supply of BRILINTA 90 mg tablets (60-count units) with a completion date of January 8, 2026. This non-set-aside contract, awarded on January 7, 2026, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. BRILINTA is a platelet aggregation inhibitor commonly used for acute coronary syndrome and cardiovascular disease management, reflecting the Defense Logistics Agency's ongoing need to supply pharmaceutical products to military healthcare systems.
This delivery order operates under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.999 billion through December 31, 2031. This comprehensive IDC serves as the primary vehicle enabling Cencora/AmerisourceBergen to supply an extensive portfolio of specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military treatment facilities and veteran healthcare programs globally. The competitively awarded structure and firm fixed pricing demonstrate AmerisourceBergen's established capability to efficiently fulfill critical pharmaceutical procurement requirements for the Department of Defense health system.
Quick answers
Who was awarded contract SPE2DR26F4ZNW?
SPE2DR26F4ZNW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F4ZNW worth?
The government has obligated $10,453 on SPE2DR26F4ZNW.
Is contract SPE2DR26F4ZNW an order under another contract?
Yes. SPE2DR26F4ZNW is a delivery order under SPE2DR25D2010, an indefinite delivery contract.
Was contract SPE2DR26F4ZNW competed?
The extent of competition for SPE2DR26F4ZNW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award